Literature DB >> 15356147

Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression.

Ulrich Mahlknecht1, Jutta Will, Audrey Varin, Dieter Hoelzer, Georges Herbein.   

Abstract

During inflammatory events, the induction of immediate-early genes, such as TNF-alpha, is regulated by signaling cascades including the JAK/STAT, NF-kappaB, and the p38 MAPK pathways, which result in phosphorylation-dependent activation of transcription factors. We observed the direct interaction of histone deacetylase (HDAC) 3, a class I histone deacetylase, with MAPK11 (p38 beta isoform) by West-Western-based screening analysis, pull-down assay, and two-hybrid system analysis. Results further indicated that HDAC3 decreases the MAPK11 phosphorylation state and inhibits the activity of the MAPK11-dependent transcription factor, activating transcription factor-2 (ATF-2). LPS-mediated activation of ATF-2 was inhibited by HDAC3 in a time- and dose-dependent manner. Inhibition of HDAC3 expression by RNA interference resulted in increased ATF-2 activation in response to LPS stimulation. In agreement with decreased ATF-2 transcriptional activity by HDAC3, HDAC3-repressed TNF gene expression, and TNF protein production observed in response to LPS stimulation. Therefore, our results indicate that HDAC3 interacts directly and selectively with MAPK11, represses ATF-2 transcriptional activity, and acts as a regulator of TNF gene expression in LPS-stimulated cells, especially in mononuclear phagocytes. Copyright 2004 The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356147     DOI: 10.4049/jimmunol.173.6.3979

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis.

Authors:  G Schett; J Zwerina; G Firestein
Journal:  Ann Rheum Dis       Date:  2007-09-07       Impact factor: 19.103

2.  Noncoding RNAs and LRRFIP1 regulate TNF expression.

Authors:  Lihua Shi; Li Song; Michael Fitzgerald; Kelly Maurer; Asen Bagashev; Kathleen E Sullivan
Journal:  J Immunol       Date:  2014-02-24       Impact factor: 5.422

3.  Increased HDAC3 and decreased miRNA-130a expression in PBMCs through recruitment HDAC3 in patients with spinal cord injuries.

Authors:  Yu-Dong Ma; Jing Fang; Hong Liu; Li Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.

Authors:  Youngmi Kim; Hyuna Kim; Hyunmi Park; Deokbum Park; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

5.  Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes.

Authors:  Hyeon-Sook Suh; Shinyeop Choi; Pallavi Khattar; Namjong Choi; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-17       Impact factor: 4.147

Review 6.  Macrophage signaling in HIV-1 infection.

Authors:  Georges Herbein; Gabriel Gras; Kashif Aziz Khan; Wasim Abbas
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

7.  Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo.

Authors:  Daniela Bosisio; Marisa Vulcano; Annalisa Del Prete; Marina Sironi; Valentina Salvi; Laura Salogni; Elena Riboldi; Flavio Leoni; Charles A Dinarello; Giampiero Girolomoni; Silvano Sozzani
Journal:  J Leukoc Biol       Date:  2008-09-09       Impact factor: 4.962

8.  Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation.

Authors:  Huaqing Zhu; Limei Shan; Peter W Schiller; Antonello Mai; Tianqing Peng
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

9.  15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter.

Authors:  Ryan Engdahl; M Alexandra Monroy; John M Daly
Journal:  Biochem Biophys Res Commun       Date:  2007-05-21       Impact factor: 3.575

10.  The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo.

Authors:  Flavio Leoni; Gianluca Fossati; Eli C Lewis; Jae-Kwon Lee; Giulia Porro; Paolo Pagani; Daniela Modena; Maria Lusia Moras; Pietro Pozzi; Leonid L Reznikov; Britta Siegmund; Giamila Fantuzzi; Charles A Dinarello; Paolo Mascagni
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.